S 4201 New Jersey Senate · 2026-2027 Regular Session

Authorizes coverage of prescriptive hormone replacement therapy.

This New Jersey bill requires private health plans, state-purchased insurance contracts, and Medicaid to cover a 12-month supply of prescription hormone replacement therapy for individuals who do not need refrigeration. The legislation defines these drugs as FDA-approved medications used to regulate hormone levels but explicitly excludes certain weight-loss drugs. While the law mandates this coverage, it allows for specific exceptions, such as limiting refills during the last quarter of a plan year if a full supply was already provided, or temporarily reducing supplies to 90 days during acute drug shortages. Additionally, insurance providers retain the ability to use standard drug management strategies to oversee how these medications are prescribed and dispensed.
Bill status in committee 1 of 4 stages cleared
Introduction
May 2026
Committee Review
Floor Vote
Governor
Introduced May 11, 2026 Last action May 11, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
1
Key actions
0
Committee
0
May 11, 2026
Introduced
Introduced in the Senate, Referred to Senate Commerce Committee
upper
1 primary · 0 co-sponsors

Sponsors

Role
Legislator
Party
State
District
P
Photo of Raj Mukherji
Raj Mukherji
DDemocratic
NJ
32